Join
Live feed
·
INSIDERFilingvia Quantisnow
Pelthos Therapeutics Inc. logo

Director Greenleaf Peter sold $20,827 worth of shares (797 units at $26.13) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 23,884 units (SEC Form 4) to satisfy withholding tax

ByQuantisnow·Wall Street's wire, on your screen.
PTHS· Pelthos Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PTHS (Pelthos Therapeutics Inc.) and more on Quantisnow.